CCRM
Rory Rafferty is an experienced program manager currently at CCRM since June 2022 and co-founder of the online coaching platform CoachÉile since March 2020. Previously, Rory held various leadership roles at Mondelēz International, including Business Unit Lead and Interim Business Unit Leader, contributing from April 2019 to June 2022. Rory also has experience as Inventory Control Team Lead at Tyco and as Operations Team Member at Merit Medical Systems, Inc., where earlier roles included Team Lead and Production Operator. Rory's expertise in laboratory work was demonstrated as a Lab Technician at Vysera Biomedical Ltd., focusing on biomimetic material technology. Academically, Rory earned a Master’s degree in Cellular Manufacturing and Therapy from the University of Galway and a Bachelor of Applied Science in Applied Biology and Biopharmaceutical Science from Galway-Mayo Institute of Technology.
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.